The question of why the same breast cancer screening program is recommended for women with different risk factors, different genetic makeups, or different backgrounds and family histories is frequently raised.

In light of this question, the idea that women's risk status should be assessed individually and screened based on these results in breast cancer screening gains importance.

Screening high-risk patients with breast MRI has been a practice with published guidelines since 2008. Contrast-enhanced mammography is also performed in high-risk patients during breast cancer screening.

There is no clear guideline-based information available for other risk groups (intermediate risk, normal risk, and low risk). Numerous studies on this topic have been conducted in recent years.

The Wisdom (Women Informed to Screen Depending on Measures of Risk) Study investigates whether a personalized approach to breast cancer screening is as safe and effective as routine annual mammographic screening.

The ASSURE (Adapting Breast Cancer Screening Strategy Using Personalized Risk Estimation) Project, a European-origin study conducted at 10 centers in 7 countries, is supported by the European Union. One goal of the project is to estimate individual risk based on breast density, age, genetic mutations, family and/or personal history, and to recommend an optimal, cost-effective, personalized screening strategy based on this risk. This study also explores how and for whom sonography and MRI should be used in addition to mammography.

Screening intervals for low-risk groups can be reduced to limit the side effects and costs of x-ray exposure during MG screening.

Your breast radiologist, who is knowledgeable about current information, will meet with you face-to-face to plan your breast cancer screening according to your risk level.

TURKISH RADIOLOGICAL ASSOCIATION Breast Cancer Screening Guidelines
TRD Breast Radiology Working Group Breast Cancer Radiological Screening Standards